This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Willow Biosciences Advances Work on THC Produced by Yeast in Canada
Company continues to eye development in the U.S. cannabis market.
Willow Biosciences Inc. has advanced its work on its proprietary yeast strain for production of tetrahydrocannabinol (THC) and plans to commercially launch in the Canadian market.
Willow's Canadian-based research and development group has developed a proprietary yeast strain and process for the production of THC, and is working toward a pilot-scale run later this year. While there is already a well-established market for THC in Canada, the company believes there is significant demand from consumer product manufacturers looking for a consistent, high-purity, odorless, flavorless THC ingredient like Willow's for the 2.0 market, which consists of vapes, edibles, beverages, concentrates and topicals.